A. “Ghrelin Treatment of Cachectic Patients with Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial,” by Keisuke Miki, Ryoji Maekura, Noritoshi Nagaya, Masamitsu Nakazato, Hiroshi Kimura, Shinsuke Murakami, Shunsuke Ohnishi, Toru Hiraga, Mari Miki, Seigo Kitada, Kenji Yoshimura, Yoshitaka Tateishi, Yasuji Arimura, Nobuhiro Matsumoto, Masanori Yoshikawa, Kenichi Yamahara, and Kenji Kangawa (PLoS ONE 7(5): e35708. doi:10.1371/journal.pone.0035708, XML, HTML, and .pdf format, 10p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0035708
B. “Accounting for Movement Increases Sensitivity in Detecting Brain Activity in Parkinson’s Disease,” by Stefan Holiga, Harald E. Moller, Tomas Sieger, Matthias L. Schroeter, Robert Jech, and Karsten Mueller (PLoS ONE 7(5): e36271. doi:10.1371/journal.pone.0036271, XML, HTML, and .pdf format, 11p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036271
C. “Concordant Signaling Pathways Produced by Pesticide Exposure in Mice Correspond to Pathways Identified in Human Parkinson’s Disease,” by Seema Gollamudi, Ashu Johri, Noel Y. Calingasan, Lichuan Yang, Olivier Elemento, and M. Flint Beal (PLoS ONE 7(5): e36191. doi:10.1371/journal.pone.0036191, XML, HTML, and .pdf format, 13p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036191
